🇺🇸 FDA
Patent

US 9314507

Methods of treatment of heart failure with natriuretic peptides

granted A61KA61K38/22A61K38/2242

Quick answer

US patent 9314507 (Methods of treatment of heart failure with natriuretic peptides) held by Capricor Therapeutics, Inc. expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Capricor Therapeutics, Inc.
Grant date
Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/22, A61K38/2242, A61K45/06, A61P